d-chiro-inositol
Small moleculeexperimental
1D-chiro-Inositol or D-chiro-inositol is a chemical substance with formula C6H12O6, one of the nine isomers of cyclohexane-1,2,3,4,5,6-hexol. The molecule has a ring of six carbon atoms, each bound to one hydrogen atom and one hydroxyl (OH) group. The hydroxyls on atoms 1, 2, and 4, in counterclockwise order, lie above the plane of the ring. The molecule being distinct from its mirror image, the compound is chiral, hence its name. Its enantiomer is 1L-chiro-inositol. — Wikipedia
Clinical trial activity
17 trials · 14 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
1
Earliest trial started Mar 10, 2018 (NCT03920787)
Timeline
Indications
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- Wikipedia1D-chiro-Inositol ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06860841 | Phase 4 | Jan 10, 2025 | Campus Bio-Medico University |
| NCT06715527 | N/A | Nov 1, 2024 | Lo.Li. Pharma, Ltd. |
| NCT06398145 | Phase 2 | Jun 1, 2024 | University of Perugia |
| NCT06314126 | N/A | Jan 1, 2024 | University of Palermo |
| NCT06158932 | N/A | Sep 8, 2023 | Citruslabs, Optify |
| NCT05348967 | N/A | Oct 14, 2022 | Lo.Li. Pharma, Ltd. |
| NCT05409872 | N/A | Sep 15, 2022 | University of Verona |
| NCT06170463 | Phase 1 | Aug 1, 2022 | Zagazig University |
| NCT05448365 | Phase 3 | Jul 1, 2022 | Lo.Li. Pharma, Ltd. |
| NCT05348941 | N/A | Jun 28, 2022 | Lo.Li. Pharma, Ltd. |
| NCT05448378 | N/A | Jun 4, 2022 | Lo.Li. Pharma, Ltd. |
| NCT05951309 | N/A | Sep 1, 2021 | Cyprus International University, Near East University, Turkey |
| NCT04745780 | N/A | Feb 10, 2021 | Lo.Li. Pharma, Ltd. |
| NCT04708249 | N/A | Jan 18, 2021 | Lo.Li. Pharma, Ltd. |
| NCT04576546 | N/A | Nov 2, 2020 | Lo.Li. Pharma, Ltd. |
| NCT04615767 | N/A | Oct 28, 2020 | AGUNCO Obstetrics and Gynecology Centre, Systems Biology Group Lab, Rome, Italy, University of Roma La Sapienza |
| NCT03920787 | N/A | Mar 10, 2018 | Lo.Li. Pharma, Ltd., University of Milan |
Showing 17 of 17 trials
Page 1 / 1
Organizations
Research & Development (14)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lo.Li. Pharma, Ltd. | For profit | 9 | 8 | 2 | 2018 |
| AGUNCO Obstetrics and Gynecology Centre | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Campus Bio-Medico University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Citruslabs | For profit | 1 | 0 | 1 | 2023 |
| Cyprus International University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Near East University, Turkey | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Optify | For profit | 1 | 1 | 1 | 2023 |
| Systems Biology Group Lab, Rome, Italy | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Milan | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Palermo | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Perugia | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Roma La Sapienza | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Verona | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Zagazig University | Academic/Hospital | 1 | 1 | 1 | 2022 |
14 organizations
Page 1 / 1